# Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure

> **NCT04428021** · PHASE2 · COMPLETED · sponsor: **A.O.U. Città della Salute e della Scienza** · enrollment: 180 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Standard Therapy Protocol (STP)
- **OTHER:** STP + Standard Plasma (SP)
- **OTHER:** STP + COVID-19 Convalescent Plasma (CP)

## Key facts

- **NCT ID:** NCT04428021
- **Lead sponsor:** A.O.U. Città della Salute e della Scienza
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2022-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04428021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04428021, "Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04428021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*